Atreca (BCEL) News Today

$0.21

-0.01 (-4.46%)

(As of 11/28/2023 ET)

Today's Range: $0.21
▼
$0.23
50-Day Range: $0.20
▼
$0.38
52-Week Range: $0.19
▼
$2.05

Volume: 258,464 shs
Average Volume: 661,921 shs
Market Capitalization: $8.41 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.75

Source

Source	Headline
	Atreca Inc Class A BCEL morningstar.com - November 16 at 8:00 AM
	Atreca to Cut About 40% of Workforce marketwatch.com - November 14 at 8:18 PM
	Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives finance.yahoo.com - November 14 at 8:18 PM
	Atreca Inc (BCEL) es.investing.com - November 2 at 9:41 AM
	BAKER BROS. ADVISORS LP Reduces Stake in Atreca Inc finance.yahoo.com - October 24 at 1:07 AM
	What's Going On With Atreca Inc Stock? benzinga.com - October 12 at 6:49 PM
	Mid-Peninsula building rode biotech's boom. Now it's showing how to survive the bust bizjournals.com - October 12 at 1:42 PM
	Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross finance.yahoo.com - September 21 at 12:32 PM
	HC Wainwright & Co. Downgrades Atreca Inc - (BCEL) msn.com - August 11 at 5:24 PM
	Stifel Downgrades Atreca Inc - (BCEL) msn.com - August 11 at 5:24 PM
	Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring finance.yahoo.com - August 11 at 12:47 AM
	Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20 msn.com - August 2 at 12:44 PM
	Atreca Approaches A Major Go/No-Go Decision msn.com - June 20 at 7:53 PM
	Stifel Nicolaus Reaffirms Their Buy Rating on Atreca (BCEL) markets.businessinsider.com - June 6 at 11:56 PM
	HC Wainwright & Co. Reiterates Atreca Inc - (BCEL) Buy Recommendation msn.com - June 5 at 5:53 PM
	Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting finance.yahoo.com - June 5 at 12:53 PM
	Atreca (BCEL) Gets a Buy from H.C. Wainwright markets.businessinsider.com - June 5 at 7:52 AM
	Atreca (NASDAQ: BCEL) fool.com - June 2 at 9:50 PM
	Stifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL) markets.businessinsider.com - May 30 at 1:48 AM
	Atreca, Inc. (BCEL) Interactive Stock Chart - Yahoo Finance ca.finance.yahoo.com - May 17 at 1:24 PM
	Atreca, Inc. (BCEL) Stock Historical Prices & Data - Yahoo Finance ca.finance.yahoo.com - May 14 at 8:13 PM
	HC Wainwright & Co. Reiterates Atreca, Inc. (BCEL) Buy Recommendation msn.com - May 12 at 7:50 AM
	Stifel Maintains Atreca, Inc. (BCEL) Buy Recommendation msn.com - May 11 at 9:49 PM
	Atreca, Inc.: Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments finanznachrichten.de - May 11 at 11:48 AM
	Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Atreca (BCEL) and Oscar Health (OSCR) markets.businessinsider.com - May 11 at 6:48 AM
	Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments finance.yahoo.com - May 10 at 7:15 PM
	Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting finance.yahoo.com - April 26 at 6:56 PM
	Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference finance.yahoo.com - April 13 at 9:28 AM
	Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now finance.yahoo.com - April 6 at 3:50 PM
	Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year? finance.yahoo.com - April 5 at 1:44 PM
	Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023 finance.yahoo.com - March 23 at 8:28 PM
	Atreca (BCEL) Earnings Dates & Reports investing.com - March 21 at 6:52 AM
	Atreca to Participate at Cowen’s 43rd Annual Health Care Conference finance.yahoo.com - March 1 at 12:03 PM
	Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target finance.yahoo.com - February 6 at 9:36 AM
	Atreca Appoints Philippe Bishop, MD as Chief Medical Officer finance.yahoo.com - January 9 at 9:42 AM
	Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update finance.yahoo.com - November 10 at 9:00 PM
	Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswire globenewswire.com - October 5 at 8:27 PM
	Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting finance.yahoo.com - October 5 at 8:27 PM
	ImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer - StreetInsider.com streetinsider.com - September 13 at 2:10 PM
	ImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer - PR Newswire prnewswire.com - September 13 at 9:03 AM
	Delivering on the Promise of New Modalities: An Interview With Yann Chong Tan, Founder & CEO, Nuevocor - Marketscreener.com marketscreener.com - September 7 at 6:59 PM
	Atreca (BCEL) Presents At 42nd Annual Global I Growth Conference - Slideshow seekingalpha.com - August 20 at 3:52 AM
	Companies Like IDEAYA Biosciences (NASDAQ:IDYA) Are In A Position To Invest In Growth - Nasdaq nasdaq.com - August 16 at 1:21 AM
	Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Nasdaq nasdaq.com - August 16 at 1:21 AM
	Rocky Mountain Chocolate Factory (NASDAQ:RMCF) May Have Issues Allocating Its Capital - Nasdaq nasdaq.com - August 16 at 1:21 AM
	What Kind Of Investors Own Most Of Atreca, Inc. (NASDAQ:BCEL)? - Nasdaq nasdaq.com - August 16 at 1:21 AM
	We're A Little Worried About Atreca's (NASDAQ:BCEL) Cash Burn Rate finance.yahoo.com - August 12 at 11:34 AM
	Stifel Nicolaus Adjusts Atreca Price Target to $12 From $14, Maintains Buy Rating - Marketscreener.com marketscreener.com - August 9 at 5:04 PM
	Atreca Reports Second Quarter 2022 Financial Results and Recent Corporate Developments - GlobeNewswire globenewswire.com - August 8 at 5:44 PM
	Atreca Reports Second Quarter 2022 Financial Results and Recent Corporate Developments finance.yahoo.com - August 8 at 5:44 PM

Get Atreca News Delivered to You Automatically

BCEL Media Mentions By Week

BCEL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCEL
News Sentiment
▼
1.87

0.87
▲
Average
Medical
News Sentiment

BCEL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCEL Articles
This Week
▼
2

0
▲
BCEL Articles
Average Week

Get Atreca News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:BCEL) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Atreca (BCEL) News Today

BCEL Media Mentions By Week

BCEL Media Sentiment

BCEL News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info